ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $11 | -71.1% | 671 | -67.0% | 0.01% | -70.8% |
| Q1 2024 | $38 | +2.7% | 2,032 | +70.5% | 0.02% | -4.0% |
| Q4 2023 | $37 | +208.3% | 1,192 | +104.1% | 0.02% | +177.8% |
| Q3 2023 | $12 | – | 584 | +4766.7% | 0.01% | – |
| Q2 2023 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 12 | -60.0% | 0.00% | – |
| Q4 2022 | $0 | – | 30 | +3.4% | 0.00% | – |
| Q3 2022 | $0 | – | 29 | +52.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 19 | -88.3% | 0.00% | -100.0% |
| Q1 2022 | $4,000 | 0.0% | 162 | -3.6% | 0.00% | -50.0% |
| Q4 2021 | $4,000 | – | 168 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |